Skip to main content

Vericel Corp

VCEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000887359

In the last 90 days, Vericel Corp insiders filed 0 open-market purchases and 3 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $2.47B in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Vericel Corp changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of VCEL: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders205202−3
Shares48.9M50.7M+1.83M (+3.7%)
Value$2.57B$2.48B−$92.0M (−3.6%)

New holders (20)

Institutions that held Vericel Corp at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to VCEL in Q3 2021
InstitutionSharesValue% of portfolio
CastleArk Alternatives, LLC153,160$7.47M0.29%
Raymond James & Associates48,028$2.34M0.00%
Moody Aldrich Partners LLC33,663$1.64M0.21%
Qube Research & Technologies Ltd21,503$1.05M0.01%
Maryland State Retirement & Pension System18,348$902.0K0.03%
V Wealth Advisors LLC10,957$535.0K0.08%
Summit Global Investments10,900$532.0K0.04%
Blueshift Asset Management, LLC7,371$360.0K0.02%
Jacobs Levy Equity Management, Inc5,904$288.0K0.00%
Skandinaviska Enskilda Banken AB (publ)5,800$283.0K0.00%
Algert Global LLC4,955$242.0K0.03%
Lido Advisors, LLC4,968$242.0K0.01%
Jump Financial, LLC4,931$241.0K0.02%
KBC Group NV3,077$150.0K0.00%
Lazard Asset Management LLC1,653$80.0K0.00%
Quantbot Technologies LP235$11.0K0.00%
Koshinski Asset Management, Inc.200$9.76K0.00%
Signaturefd, LLC155$8.00K0.00%
First Horizon Advisors, Inc.82$4.00K0.00%
Global Retirement Partners, LLC61$3.00K0.00%

Sold out (23)

Institutions that held Vericel Corp at the end of Q2 2021 and filed for Q3 2021 without it.